EMERYVILLE, Calif., Sept. 2, 2025 /PRNewswire/ -- Amyris, Inc. is pleased to announce the appointment of Dr. Sunil Chandran as Chief Technology Officer. Following the successful reset of its core ...
EMERYVILLE, Calif., May 2, 2023 /PRNewswire/ -- Amyris, Inc. (AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ ...
EMERYVILLE, Calif., May 21, 2018 (GLOBE NEWSWIRE) -- Leading biotech firm Amyris, Inc. (Nasdaq:AMRS), will host its annual investor conference, BioDisrupt, on May 22, 2018 at the company’s Emeryville ...
EMERYVILLE, Calif. and WESTCHESTER, Ill., May 29, 2025 /PRNewswire/ -- Amyris, Inc., a vertically integrated synthetic biology company and leading innovator in the field of industrial biotechnology, ...
Amyris will take complete control of the Precision Fermentation Plant in Barra Bonita, Brazil, as part of the new agreement. As a result, Ingredion Incorporated (NYSE:INGR) is granted exclusive access ...
EMERYVILLE, Calif., May 29, 2025 /PRNewswire/ -- Amyris, Inc., a vertically integrated synthetic biology company and leading innovator in the field of industrial biotechnology, today announced that it ...
EMERYVILLE, Calif., July 28, 2022 /PRNewswire/ -- Amyris, Inc. (AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its ...
Amyris saw the highest growth of 349% in patent filings in February and 99% in grants in January in Q1 2024. Compared to Q4 2023, Q1 2024 saw an increase in patent filings by 49% and grants by 99%.
Amyris takes full ownership of Brazilian precision fermentation plant and Ingredion obtains exclusive access to fermented Reb M technology Amyris is a vertically integrated synthetic biology company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results